CSL (ASX: CSL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CSL Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CSL (ASX: CSL)
Latest News
Healthcare Shares
Down 4% in 3 days, should you buy the dip on CSL shares?
Blue Chip Shares
Here's why analysts rate these blue chip ASX 200 shares as buys
Blue Chip Shares
Experts say these strong blue chip ASX 200 shares are buys for 2023
Broker Notes
Bell Potter says these are some of the best ASX shares to buy for 2023
How to invest
Stock market millionaire: I'd put $500 a month into the ASX 200 to aim for 7 figures
Healthcare Shares
CSL share price slumps as new CEO appointed
Healthcare Shares
CSL share price on watch as CEO announces retirement
Healthcare Shares
Why is the CSL share price in the spotlight on Wednesday?
Healthcare Shares
If you bought 100 shares of CSL 10 years ago, this is how much you would have today
How to invest
To retire early, I'd invest $100 each week in ASX 200 shares
Share Market News
5 popular ASX 200 stocks I'm avoiding, plus one that still looks dirt cheap
Materials Shares
Is Core Lithium the hottest stock on the ASX 200 right now?
Frequently Asked Questions
-
CSL was listed on the ASX in June 1994.
-
CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.
Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.
-
CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.
-
CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents.
CSL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CSL
CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.
CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.
CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).
The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.
